Possible mechanism for the frequency-dependent increases in the cardiac contraction in monkey

Area of Science:

• Cardiovascular Physiology
• Cellular Electrophysiology
• Pharmacology

Background:

• Cardiac muscle contractility exhibits frequency-dependent increases, a phenomenon not fully understood at the molecular level.
• The sarcolemmal sodium-potassium adenosine triphosphatase (Na+,K+-ATPase) is crucial for maintaining cellular ion gradients in cardiomyocytes.

Purpose of the Study:

• To investigate the role of sarcolemmal Na+,K+-ATPase inhibition in mediating frequency-dependent increases in papillary muscle contractility.
• To determine if specific pharmacological agents that inhibit or do not inhibit Na+,K+-ATPase affect this phenomenon.

Main Methods:

• Experiments were conducted on monkey papillary muscles.
• The effects of ouabain and KCl-free Krebs-Ringer solution (Na+,K+-ATPase inhibitors) on contractility were assessed.
• The effects of epinephrine and quinidine (non-inhibitors at tested concentrations) were also evaluated.

Main Results:

• Ouabain and KCl-free Krebs-Ringer solution abolished the frequency-dependent increases in contractility.
• Epinephrine and quinidine did not alter these frequency-dependent increases.
• These findings suggest a link between Na+,K+-ATPase activity and enhanced contractility at higher stimulation frequencies.

Conclusions:

• The results strongly indicate that inhibition of the sarcolemmal Na+,K+-ATPase is the mechanism underlying the frequency-dependent increases in papillary muscle contractility.
• This study identifies a key molecular player in the regulation of cardiac contractility in response to changes in heart rate.